Archive for February 2010

European Counterfeit Drug Market Worth more than $14 Billion

At the Partnership for Safe Medicines (PSM), we've long cautioned consumers about the dangers of counterfeit drugs—a growing issue affecting all corners of the globe. Now, the Pfizer-commissioned study, "Cracking Counterfeit Europe," has estimated that the counterfeit medicines market in Europe is worth more than $14 billion. The investigation, which covered 14 European countries, comes…


$12M in Counterfeit Drugs Seized in Southeast Asia

View larger map An international police operation led to the seizure of $20M in counterfeit and illegal medicines, including antibiotics, anitimalarials, contraceptives, anti-tetanus vaccines, aspirin and drugs to treat erectile dysfunction. An estimated $12M were counterfeits with the remaining $8M found to be drugs that were “expired, diverted or unregistered.” Who: Medical Products Counterfeiting and…


Twohig M, Skilton SJ, Fujimoto G, Ellor N, Plumb RS. Rapid detection and identification of counterfeit of adulterated products of synthetic phosphodiesterase type-5 inhibitors with an atmospheric solids analysis probe. Drug Test Anal. 2010;2(2):45-50.

The market success of the three approved synthetic phosphodiesterase type-5 (PDE-5) inhibitors for the treatment of erectile dysfunction has led to an explosion in counterfeit versions of these drugs. In parallel a large market has developed for herbal products claimed to be natural alternatives to these synthetic drugs. The herbal products are heavily advertised on…